Pharmaceutical Project Management

Encompassing the full spectrum of project management’s role and responsibility encountered in the pharmaceutical industry, Pharmaceutical Project Management outlines the key objectives, risks, and challenges of each stage of the pharmaceutical lifecycle, from discovery and preclinical phases through clinical development, manufacturing, registration, and launch.

New updated material includes:

expert recommendations and informative articles on decision-making
planning principles and planning systems
management of subcontracted development
manufacturing project management
team leadership and skill sets
drug development strategies

It covers primary project management objectives, functions, and descriptions of the nature and execution of work activities in a clear and reader-friendly format to illustrate key characteristics and objectives, assist managers in projecting the risks and challenges of each development option, and supply concise recommendations for successful project planning.

Author Biography

Tony Kenedy is Vice President of Development at Trigen, Ltd in London, U.K. Dr. Kennedy, a Medical Research Council Postdoctoral Research Fellow at The School of Pharmacy, London University, U.K., was awarded his Ph.D. by London University, U.K. and was previously the Global Head of Project Management at Roche, Switzerland. He was the editor of the first edition of Pharmaceutical Project Management which was published by Marcel Dekker in 1998, and his career has been devoted to the discovery and development of novel drugs while working in large pharmaceutical and small biotech companies. Dr. Kennedy has directed global drug development teams in several therapeutic areas including cardiovascular, gastrointestinal, infectious disease, rheumatology and oncology, and led the Roche-Gilead joint development team that took the flu antiviral Tamiflu to registration three years after the discovery of the molecule.